Bibliography
- Zhornitsky S, Rizkallah E, Pampoulova T, Antipsychotics for the treatment of substance use disorders in patients with and without comorbid psychosis. J Clin Psychopharmacol 2010;30:417-24
- Green AI, Noordsy DL, Brunette MF, Substance abuse and schizophrenia: pharmacotherapeutic intervention. J Subst Abuse Treat 2008;34:61-71
- Kampman KM, Pettinati HM, Lynch KG, A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of type A and type B alcoholism. J Clin Psychopharmacol 2007;27:344-51
- Monnelly EP, Ciraulo DA, Knapp C, Quetiapine for treatment of alcohol dependence. J Clin Psychopharmacol 2004;24:532-5
- Sattar SP, Bhatia SC, Petty F. Potential benefits of quetiapine in the treatment of substance dependence disorders. J Psychiatry Neurosci 2004;29:452-7
- Pinkofsky HB, Hahn AM, Campbell FA, Reduction of opioid-withdrawal symptoms with quetiapine. J Clin Psychiatry 2005;66:1285-8
- Kennedy A, Wood AE, Saxon AJ, Quetiapine for the treatment of cocaine dependence: an open-label trial. J Clin Psychopharmacol 2008;28:221-4
- Mauri MC, Volonteri LS, Fiorentini A, Two weeks' quetiapine treatment for schizophrenia, drug-induced psychosis and borderline personality disorder: a naturalistic study with drug plasma levels. Expert Opin Pharmacother 2007;8:2207-13
- West R, Gossop M. Overview: a comparison of withdrawal symptoms from different drug classes. Addiction 1994;89:1483-9
- Baune BT. New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine. Neuropsychiatr Dis Treat 2008;4:1181-91
- Bogart GT, Chavez B. Safety and efficacy of quetiapine in bipolar depression. Ann Pharmacother 2009;43:1848-56
- Substance Abuse and Mental Health Services Administration (SAMHSA). Polydrug admission: 2002. The Drug and Alcohol Services Information System Report 2005
- Kenna GA, Nielsen DM, Mello P, Pharmacotherapy of dual substance abuse and dependence. CNS Drugs 2007;21:213-37
- Sobell LC, Sobell MB. Timeline follow-back: a technique for assessing self-reported ethanol consumption. In: Litten JARZ, editor, Measuring alcohol consumption: psychosocial and biological methods. Humana Press, Totowa, NJ; 1992;41-72
- Drake RE, Osher FC, Noordsy DL, Diagnosis of alcohol use disorders in schizophrenia. Schizophr Bull 1990;16:57-67
- Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-76
- Addington D, Addington J, Maticka-Tyndale E, Reliability and validity of a depression rating scale for schizophrenics. Schizophr Res 1992;6:201-8
- Levin FR, Evans SM, Coomaraswammy S, Flupenthixol treatment for cocaine abusers with schizophrenia: a pilot study. Am J Drug Alcohol Abuse 1998;24:343-60
- Zhornitsky S, Stip E, Pampoulova T, Extrapyramidal symptoms in substance abusers with and without schizophrenia and in non-abusing patients with schizophrenia. Mov Disord 2010;25:2188-94
- Beck AT, Steer RA, Brown GK. Manual for the beck depression inventory-II. Psychological Corporation, San Antonio, TX; 1996
- Atasoy N, Erdogan A, Yalug I, A review of liver function tests during treatment with atypical antipsychotic drugs: a chart review study. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:1255-60
- Potvin S, Stip E, Lipp O, Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial. Curr Med Res Opin 2006;22:1277-85
- Martinotti G, Andreoli S, Di Nicola M, Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics. Hum Psychopharmacol 2008;23:417-24
- Holbrook AM, Crowther R, Lotter A, Diagnosis and management of acute alcohol withdrawal. CMAJ 1999;160:675-80
- Miller NS. Pharmacotherapy in alcoholism. J Addict Dis 1995;14:23-46
- Oulis P, Konstantakopoulos G. Pregabalin in the treatment of alcohol and benzodiazepines dependence. CNS Neurosci Ther 2010;16:45-50
- Keller R, Mongini F. Switch to quetiapine in antipsychotic agent-related hyperprolactinemia. Neurol Sci 2002;23:233-5
- Nakajima M, Terao T, Iwata N, Switching female schizophrenic patients to quetiapine from conventional antipsychotic drugs: effects on hyperprolactinemia. Pharmacopsychiatry 2005;38:17-19
- Tschoner A, Engl J, Rettenbacher M, Effects of six second generation antipsychotics on body weight and metabolism – risk assessment and results from a prospective study. Pharmacopsychiatry 2009;42:29-34